Whole-genome and transcriptional analysis of treatment-emergent small-cell neuroendocrine prostate cancer demonstrates intraclass heterogeneity

Rahul R. Aggarwal, David A. Quigley, Jiaoti Huang, Li Zhang, Tomasz M. Beer, Matthew B. Rettig, Rob E. Reiter, Martin E. Gleave, George V. Thomas, Adam Foye, Denise Playdle, Paul Lloyd, Kim N. Chi, Christopher P. Evans, Primo N. Lara, Felix Y. Feng, Joshi J. Alumkal, Eric J. Small

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Therapeutic resistance in metastatic castrationresistant prostate cancer (mCRPC) can be accompanied by treatment-emergent small-cell neuroendocrine carcinoma (t-SCNC), a morphologically distinct subtype. We performed integrative wholegenome and -transcriptome analysis of mCRPC tumor biopsies including paired biopsies after progression, and multiple samples from the same individual. t-SCNC was significantly less likely to have amplification of AR or an intergenic ARenhancer locus, and demonstrated lower expression of AR and its downstream transcriptional targets. Genomic and transcriptional hallmarks of t-SCNC included biallelic loss of RB1, elevated expression levels of CDKN2A and E2F1, and loss of expression of the AR and AR-responsive genes including TMPRSS2 and NKX3-1. We identified three tumors that converted from adenocarcinoma to t-SCNC and demonstrate spatial and temporal intrapatient heterogeneity of metastatic tumors harboring adenocarcinoma, t-SCNC, or mixed expression phenotypes, with implications for treatment strategies in which dual targeting of adenocarcinoma and t-SCNC phenotypes may be necessary.

Original languageEnglish (US)
Pages (from-to)1235-1240
Number of pages6
JournalMolecular Cancer Research
Volume17
Issue number6
DOIs
StatePublished - Jun 1 2019

ASJC Scopus subject areas

  • Molecular Biology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Whole-genome and transcriptional analysis of treatment-emergent small-cell neuroendocrine prostate cancer demonstrates intraclass heterogeneity'. Together they form a unique fingerprint.

  • Cite this

    Aggarwal, R. R., Quigley, D. A., Huang, J., Zhang, L., Beer, T. M., Rettig, M. B., Reiter, R. E., Gleave, M. E., Thomas, G. V., Foye, A., Playdle, D., Lloyd, P., Chi, K. N., Evans, C. P., Lara, P. N., Feng, F. Y., Alumkal, J. J., & Small, E. J. (2019). Whole-genome and transcriptional analysis of treatment-emergent small-cell neuroendocrine prostate cancer demonstrates intraclass heterogeneity. Molecular Cancer Research, 17(6), 1235-1240. https://doi.org/10.1158/1541-7786.MCR-18-1101